Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: A study on 476 Stockholm women, using PCR for detection and typing of HPV

Human Pathology

Volumn 28, Issue 8, 1997, Pages 899-904

  Kalantari, Mina ^b   Karlsen, Frank ^b   Johansson, Bo ^b   Sigurjonsson, Thore ^b   Wärleby, Bengt ^b   Hagmar, Bjørn ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

Atypical cells of unknown significance; Cervical intraepithelial neoplasia; Dysplasia of cervix; Human papillomavirus; Polymerase chain reaction; Squamous intraepithelial lesion

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; VIRUS TYPING; WART VIRUS;

EID: 0030861034     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90004-6     Document Type: Article

References (45)

1. Nasiell K, Roger V, Nasiell M: Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 67:665-669, 1986
2. Wright TC, Kurman RJ: A critical review of the morphologic classification systems of preinvasive lesions of the cervix: The scientific basis for shifting the paradigm. Papilloma Virus Report 5:175-182, 1994
3. Kataja V, Syrjänen K, Mäntyjärvi R, et al: Prospective followup of cervical HPV infections: Life table analysis of histopathological. cytological and colposcopic data. Eur J Epidemiol 5:1-7, 1989
4. Syrjänen K, Kataja V, Yliskoski M, et al: Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda system. Obstet Gynecol 79:675-682, 1992
5. zur Hausen H: Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 49:4677-4681, 1989
6. zur Hausen H: Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 186:131-156, 1994
7. Solomon D: Screening for cervical cancer: Prospects for the future. J Natl Cancer Inst 85:1018-1019, 1993
8. Mayelo V, Garaud P, Renjard L, et al: Cell abnormalities associated with human papillomavirus-induced squamous intraepithelial cervical lesions: Multivariate data analysis. Am J Clin Pathol 101:13-18, 1994
9. Bonfiglio TA, Stoler MH: Human papillomavirus and cancer of the uterine cervix. HUM PATHOL 19:621-622, 1988
10. Kiviat NB, Koutsky LA: Specific human papillomavirus types as the causal agents of most cervical intraepithelial neoplasia: Implications for current views and treatment. J Natl Cancer Inst 85:934-935, 1993
11. Schiffman MH: Epidemiology of cervical human papillomavirus infections. Curr Top Microbiol Immunol 186:55-81, 1994
12. Bergeron C, Barrasso R, Beaudenon S, et al: Human papillomaviruses associated with cervical intraepithelial neoplasia. Am J Surg Pathol 16:641-649, 1992
13. Anderson SM, Brooke PK, Van Eyck SL, et al: Distribution of human papillomavirus types in genital lesions from two temporally distinct populations determined by in situ hybridization. HUM PATHOL 24:547-553, 1993
14. Gaarenstroom KN, Melkert P, Walboomers JM, et al: Human papillomavirus DNA and genotypes: Prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynecol Cancer 4:73-78, 1994
15. Downey GP, Bavin PJ, Deery AR, et al: Relation between human papillomavirus type 16 and potential for progression of minor grade cervical disease. Lancet 344:432-435, 1994
16. Herrington CS, Evans MF, Hallam NF, et al: Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities. Br J Cancer 71:206-209, 1995
17. Burger MPM, Hollema H, Pieters WJLM, et al: Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities. Br Med J 310:94-95, 1995
18. De Roda Husman A-M, Walboomers JMM, Meijer CJLM, et al: Analysis of cytomorphological abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 56:802-806, 1994
19. Cromme FV, Meijer CJLM, Snijders PJF, et al: Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 67:1372-1380, 1993
20. Skyldberg B, Hagmar B, Johansson B, et al: HPV detection in cytological cases with condylomatous or dysplasic changes: A study with PCR and in situ hybridization on cytological material. Diagn Cytopathol 13:8-14, 1995
21. Skyldberg B, Kalantari M, Kärki M, et al: Detection of HPV-infection in tissue blocks by in situ hybridization as compared to a PCR procedure. HUM PATHOL 22:578-582, 1991
22. Raisi O, Ghirardini C, Aloisi P, et al: HPV typing of cervical squamous lesions by in situ HPV DNA hybridization: Influence of HPV type and therapy on the follow-up of low-grade squamous cervical disease. Diagn Cytopathol 11:28-32, 1994
23. van den Brule AJC, Walboomers JMM, Du Maine M, et al: Differences in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 48:404-408, 1991
24. Meijer CJ, van den Brule AJ, Snijders PJ, et al: Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: Possible implications for cervical cancer screening. IARC Sci Pub 119:271-281, 1992
25. Konno O, Sato S, Yajima A: Progression of squamous cell carcinoma of the uterine cervix from cervical intraepithelial neoplasia infected with human papillomavirus: A retrospective follow-up study by in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 11:105-112, 1992
26. Karlsen F, Kristensen G, Holm R, et al: High incidence of human papillomavirus in 146 cervical carcinoma: A study using three different human papillomavirus consensus primers, and detecting viral genome with putative deletion. Eur J Cancer 31A:1511-1516, 1995
27. Hagmar B, Christensen JJP, Johansson B, et al: Implications of human papillomavirus type for survival in cervical squamous cell carcinoma. Int J Gynecol Cancer 5:341-345, 1995
28. Matsukura T, Sugase M: Identification of genital human papillomaviruses in cervical biopsy specimens: Segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer 61:13-22, 1995
29. Ho GY, Burk RD, Klein S, et al: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87:1365-1371, 1995
30. McLachlin CM, Tate JE, Zitz JC, et al: Human papillomavirus type 18 and intraepithelial lesions of the cervix. Am J Pathol 144:141-147, 1994
31. Ferenczy A: Viral testing for genital human papillomavirus infections: Recent progress and clinical potentials. Int J Gynecol Cancer 5:321-328, 1995
32. Willet GD, Kurman RJ, Reid R, et al: Correlation of the histologic appearance of intraepithelial neoplasia of the cervix with human papillomavirus types. Int J Gynecol Pathol 8:18-25, 1989
33. Johnson MA, Blomfield PI, Bevan IS, et al: Subtypes of human papillomavirus 16 in cervical tissue. Lancet 2:1342, 1989
34. Ellis JRM, Keating PJ, Baird J, et al: The association of an HPV 16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1:464-470, 1995
35. Icenogle JP, Clancy KA, Lin SY: Sequence variation in the capsid protein genes of human papaillomavirus type 16 and type 31. Virology 214:664-669, 1995
36. Tierney RJ, Ellis JRM, Winter H, et al: PCR for the detection of cervical HPV 16 infection: The need for standardization. Int J Cancer 54:700-701, 1993
37. van Ranst M, Tachezy R, Delius H, et al: Taxonomy of the human papillomaviruses. Papilloma Virus Report 4:61-65, 1993
38. Kuhler-Obbarius C, Milde-Langosch K, Helling-Giese G, et al: Polymerase chain reaction-assisted papillomavirus detection in cervicovaginal smears: Stratification by clinical risk and cytology reports. Virchows Arch 425:157-163, 1994
39. Nuovo GJ, Darfler MM, Impraim CC, et al: Occurrence of multiple types of human papillomavirus in genital tract lesions: Analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol 138:53-58, 1991
40. Downey GP, Bavin PJ, Deery AR, et al: Relation between human papillomavirus type 16 and potential for progression of minorgrade cervical disease. Lancet 344:432-435, 1994
41. van Oortmarssen GJ, Habbema JDF: Epidemological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 64:559-565, 1991
42. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al: The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int J Cancer 61:306-311, 1995
43. Nuovo GJ, Walsh LL, Gentile JL, et al: Correlation of the Papanicolaou smear and human papillomavirus type in women with biopsy-proven cervical squamous intraepithelial lesions. Am J Clin Pathol 96:544-548, 1991
44. Kjaer SK, van den Brule AJ, Bock JE, et al: Human papillomavirus: The most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 65:601-606, 1996
45. Jenkins D, Sherlaw-Johnson C, Gallivan S: Can papilloma virus testing be used to improve cervical cancer screening? Int J Cancer 65:768-773, 1996